Arovella Therapeutics
$0.118500
7
+$0.00+0% Wednesday 19:09
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
142.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
2SepExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.01
-0
-0
-0
Expected EPS
-0.00619866
Actual EPS
N/A
Financials
-5,657.65%Profit Margin
Unprofitable173,564.58Revenue
-9.82MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.
Show more...
CEO
ISIN
AU0000182784
Listings
0 Comments
Share your thoughts
FAQ
What is Arovella Therapeutics stock price today?▼
The current price of ARVEF is $0.12 USD — it has increased by +0% in the past 24 hours. Watch Arovella Therapeutics stock price performance more closely on the chart.
What is Arovella Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Arovella Therapeutics stocks are traded under the ticker ARVEF.
What is Arovella Therapeutics market cap?▼
Today Arovella Therapeutics has the market capitalization of 142.34M
What is Arovella Therapeutics revenue for the last year?▼
Arovella Therapeutics revenue for the last year amounts to 173,564.58 USD.
What is Arovella Therapeutics net income for the last year?▼
ARVEF net income for the last year is -9.82M USD.
In which sector is Arovella Therapeutics located?▼
Arovella Therapeutics operates in the Other sector.
When did Arovella Therapeutics complete a stock split?▼
The last stock split for Arovella Therapeutics was on November 14, 2019 with a ratio of 1:25.